Employees: 11 (2023.0)Legal category: 5785Size: PMECreation date: 1993-08-30 (32 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: MENNECY (91540), Essonne
SNC PHARMACIE FLAHAUT ET ARCHAMBAULT : revenue, balance sheet and financial ratios
SNC PHARMACIE FLAHAUT ET ARCHAMBAULT is a French company
founded 32 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in MENNECY (91540),
this company of category PME
shows in 2022 a revenue of 5.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SNC PHARMACIE FLAHAUT ET ARCHAMBAULT (SIREN 392361002)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
5 306 186 €
4 714 642 €
4 731 746 €
4 565 014 €
N/C
4 014 651 €
Net income
65 537 €
35 042 €
209 687 €
310 303 €
83 496 €
54 910 €
91 224 €
65 145 €
64 221 €
EBITDA
N/C
N/C
N/C
459 571 €
141 810 €
130 144 €
149 536 €
N/C
77 212 €
Net margin
N/C
N/C
N/C
5.8%
1.8%
1.2%
2.0%
N/C
1.6%
Revenue and income statement
In 2025, SNC PHARMACIE FLAHAUT ET ARCHAMBAULT generates positive net income of 66 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 64 k€ -> 66 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
65 537 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 887%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 6%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
886.599%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
6.35%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SNC PHARMACIE FLAHAUT ET ARCHAMBAULT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
87.259
75.014
56.17
40.287
24.917
197.637
122.056
104.045
886.599
Financial autonomy
37.696
39.365
44.625
46.476
50.274
21.51
31.17
31.301
6.35
Repayment capacity
9.203
None
3.67
3.601
1.925
2.527
None
None
None
Cash flow / Revenue
1.513%
None%
2.561%
2.015%
2.569%
6.571%
None%
None%
None%
Sector positioning
Debt ratio
886.62025
2023
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Watch+12 pts over 3 years
In 2025, the debt ratio of SNC PHARMACIE FLAHAUT ET ... (886.60) ranks in the top 25% of the sector. This ratio measures the weight of debt relative to equity. A high ratio may indicate excessive dependence on external financing.
Financial autonomy
6.35%2025
2023
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Watch
In 2025, the financial autonomy of SNC PHARMACIE FLAHAUT ET ... (6.3%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 101.50. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
101.495
Liquidity indicators evolution SNC PHARMACIE FLAHAUT ET ARCHAMBAULT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
77.667
71.98
72.953
71.524
73.426
100.482
106.919
99.451
101.495
Interest coverage
14.563
None
5.8
12.144
3.655
3.337
None
None
None
Sector positioning
Liquidity ratio
101.52025
2023
2024
2025
Q1: 131.03
Med: 182.25
Q3: 258.64
Watch
In 2025, the liquidity ratio of SNC PHARMACIE FLAHAUT ET ... (101.50) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SNC PHARMACIE FLAHAUT ET ARCHAMBAULT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
207 477 €
0 €
202 550 €
158 987 €
132 811 €
171 708 €
0 €
0 €
0 €
Inventory turnover (days)
24
0
23
23
24
23
0
0
0
Customer payment term (days)
0
75
1
0
0
5
0
0
0
Supplier payment term (days)
47
924
44
50
51
43
0
0
0
Positioning of SNC PHARMACIE FLAHAUT ET ARCHAMBAULT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of SNC PHARMACIE FLAHAUT ET ARCHAMBAULT is estimated at
1 041 063 €
(range 706 470€ - 1 633 571€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
706k€1041k€1633k€
1 041 063 €Range: 706 470€ - 1 633 571€
NAF 5 année 2025
Valuation method used
Net Income Multiple
65 537 €
×
15.9x
=1 041 063 €
Range: 706 470€ - 1 633 571€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SNC PHARMACIE FLAHAUT ET ARCHAMBAULT with other companies in the same sector:
Frequently asked questions about SNC PHARMACIE FLAHAUT ET ARCHAMBAULT
What is the revenue of SNC PHARMACIE FLAHAUT ET ARCHAMBAULT ?
The revenue of SNC PHARMACIE FLAHAUT ET ARCHAMBAULT in 2022 is 5.3 M€.
Is SNC PHARMACIE FLAHAUT ET ARCHAMBAULT profitable?
Yes, SNC PHARMACIE FLAHAUT ET ARCHAMBAULT generated a net profit of 66 k€ in 2025.
Where is the headquarters of SNC PHARMACIE FLAHAUT ET ARCHAMBAULT ?
The headquarters of SNC PHARMACIE FLAHAUT ET ARCHAMBAULT is located in MENNECY (91540), in the department Essonne.
Where to find the tax return of SNC PHARMACIE FLAHAUT ET ARCHAMBAULT ?
The tax return of SNC PHARMACIE FLAHAUT ET ARCHAMBAULT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SNC PHARMACIE FLAHAUT ET ARCHAMBAULT operate?
SNC PHARMACIE FLAHAUT ET ARCHAMBAULT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart